94 related articles for article (PubMed ID: 15863134)
1. Management strategies for stage IB2 cervical cancer: a cost-effectiveness analysis.
Rocconi RP; Estes JM; Leath CA; Kilgore LC; Huh WK; Straughn JM
Gynecol Oncol; 2005 May; 97(2):387-94. PubMed ID: 15863134
[TBL] [Abstract][Full Text] [Related]
2. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
Jewell EL; Kulasingam S; Myers ER; Alvarez Secord A; Havrilesky LJ
Gynecol Oncol; 2007 Dec; 107(3):532-40. PubMed ID: 17900674
[TBL] [Abstract][Full Text] [Related]
3. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
Cohn DE; Huh WK; Fowler JM; Straughn JM
Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
[TBL] [Abstract][Full Text] [Related]
5. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Chen H; Liang C; Zhang L; Huang S; Wu X
Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
Gynecol Oncol; 2007 Jan; 104(1):64-9. PubMed ID: 16904170
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
9. Management of cervical cancer.
Kesic V
Eur J Surg Oncol; 2006 Oct; 32(8):832-7. PubMed ID: 16698223
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemotherapy followed by radical surgery compared to concurrent chemotherapy in stage I b2- III b cervical cancer].
Abe A; Furumoto H; Nakayama A; Nishimura M; Irahara M; Ikushima H
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1535-9. PubMed ID: 18799907
[TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
12. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
13. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.
Goksedef BP; Kunos C; Belinson JL; Rose PG
Am J Obstet Gynecol; 2009 Feb; 200(2):175.e1-5. PubMed ID: 19091305
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
Loizzi V; Cormio G; Vicino M; Selvaggi L
Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for abnormal early pregnancy: a cost-effectiveness analysis.
Rocconi RP; Chiang S; Richter HE; Straughn JM
J Reprod Med; 2005 Jul; 50(7):486-90. PubMed ID: 16130844
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
18. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
